CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-23 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | ZAVRL FRANK Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | BOGER JOSHUA S Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | Sabbagh Marwan Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | Poulton Jeffrey V. Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | Hollingsworth Jane H Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-06-23 | Gregoire Sylvie Director | Grant or award · Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2025-05-14 | ELDER WILLIAM ROBERT CFO, GC & Secretary | Purchase | +4,233 | $8.46 | $36K | 5,500 |
| 2025-02-04 | Gregoire Sylvie Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-02-04 | ELDER WILLIAM ROBERT CFO & GC | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-02-04 | Cobuzzi Robert Joseph Jr. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-02-04 | Blackburn Kelly SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-02-04 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-08-27 | ELDER WILLIAM ROBERT CFO & GC | Purchase | +1,000 | $18.16 | $18K | 1,267 |
| 2024-06-14 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-06-14 | BOGER JOSHUA S Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-06-14 | Gregoire Sylvie Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-06-14 | Hollingsworth Jane H Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-06-14 | Poulton Jeffrey V. Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-06-14 | Sabbagh Marwan Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 |
Page 3 of 17 · 321 trades